Katie Peng
Director/Board Member en SCHOLAR ROCK HOLDING CORPORATION .
Fortuna: 476 412 $ al 31/03/2024
Perfil
Katie Peng is an Independent Director at Scholar Rock Holding Corp., a Director at California Life Sciences Association, and an Independent Director at Adicet Bio, Inc. She was previously a Senior Vice President & Head-OMNI Business Unit at Genentech, Inc. She received an undergraduate degree from the University of California, Berkeley and an MBA from Kelley School of Business.
Additionally, she is currently the Chief Commercial Officer at Denali Therapeutics, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/04/2024 | 26 825 ( 0.03% ) | 476 412 $ | 31/03/2024 | |
ADICET BIO INC
-.--% | 09/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Katie Peng
| Empresas | Cargo | Inicio |
|---|---|---|
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 27/09/2021 |
| ADICET BIO, INC. | Director/Board Member | 10/07/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 15/02/2024 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | - |
Antiguos cargos conocidos de Katie Peng.
| Empresas | Cargo | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formación de Katie Peng.
| University of California, Berkeley | Undergraduate Degree |
| Kelley School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| ADICET BIO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
- Bolsa de valores
- Insiders
- Katie Peng
